FUBP1 (Far Upstream Element Binding Protein 1), also known as FBP1 (FUSE Binding Protein 1), is a multifunctional DNA and RNA-binding protein that plays critical roles in transcriptional regulation, RNA processing, and the DNA damage response. Originally identified as a regulator of c-Myc expression through binding to the far upstream element (FUSE), FUBP1 has emerged as an important player in neurodegeneration, particularly in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). [@bacher2020]
The identification of FUBP1 mutations in ALS/FTD patients has highlighted the importance of transcriptional regulation and DNA repair in maintaining neuronal health. As a master regulator of gene expression, FUBP1 sits at the intersection of multiple pathways critical for neuronal survival. [@brenner2023]
| Property |
Value |
Reference |
| Gene Symbol |
FUBP1 |
|
| Alternative Names |
FBP1, FUSE binding protein 1 |
|
| Full Name |
Far Upstream Element Binding Protein 1 |
|
| Chromosomal Location |
1p31.1 |
|
| NCBI Gene ID |
2260 |
|
| OMIM |
608470 |
|
| Ensembl ID |
ENSG00000107223 |
|
| UniProt ID |
Q96AE4 |
|
¶ Protein Structure and Domains
FUBP1 is a ~650 amino acid protein with multiple functional domains:
¶ Functional Domains
- N-terminal transactivation domain: Interacts with transcriptional co-activators
- Central KH domain: RNA/DNA binding domain (~100 aa)
- C-terminal domains: Additional nucleic acid binding capacity
The KH domain is the critical nucleic acid-binding module:
- Recognizes single-stranded DNA (FUSE) and RNA
- Mediates protein-protein interactions
- Essential for transcriptional regulation function
FUBP1 regulates gene expression through multiple mechanisms:
c-Myc Regulation
- Binds to FUSE upstream of c-Myc promoter
- Modulates RNA polymerase II processivity
- Coordinates transcriptional elongation
- Links nutritional/growth signals to Myc expression [@duncan1994]
Broader Transcriptional Network
- Regulates numerous target genes beyond Myc
- Functions as both activator and repressor
- Integrates signaling inputs
- Controls metabolic gene expression
FUBP1 participates in RNA metabolism:
- mRNA stability: Affects transcript half-life
- Alternative splicing: Influences splice site selection
- Translation regulation: Modulates protein synthesis
- RNA localization: Affects subcellular RNA distribution [@hong2019]
FUBP1 is involved in DNA repair:
- Response to damage: Rapid recruitment to DNA lesions
- Repair pathway: Participates in repair of double-strand breaks
- Replication stress: Response to replication fork stalling
- Genomic stability: Maintains chromosome integrity [@liu2021]
| Tissue |
Expression Level |
Notes |
| Brain |
High |
Cortex, hippocampus, cerebellum |
| Liver |
High |
Metabolic functions |
| Testis |
High |
Germ cell development |
| Heart |
Moderate |
Cardiac muscle |
| Kidney |
Moderate |
Epithelial cells |
In the nervous system, FUBP1 shows:
- Neuronal expression: High in pyramidal neurons
- Glial expression: Detected in astrocytes and oligodendrocytes
- Subcellular localization: Nuclear and cytoplasmic
- Stress responsiveness: Altered by DNA damage and cellular stress
FUBP1 is genetically associated with ALS:
Genetic Evidence
- FUBP1 mutations identified in ALS/FTD patients
- Autosomal dominant inheritance pattern
- Both missense and loss-of-function variants
- Pathogenic mechanisms involve loss-of-function [@brenner2023]
Mechanistic Pathways
- Transcriptional dysregulation: Impaired c-Myc and target gene regulation
- DNA repair deficiency: Reduced DNA damage response
- Metabolic dysfunction: Altered cellular energetics
- Stress vulnerability: Reduced ability to respond to cellular stress
FUBP1 mutations also cause FTD:
- Overlapping clinical spectrum with ALS
- Behavioral variant FTD presentation
- Language variant FTD (particularly)
- Often co-occurs with ALS features
Potential FUBP1 involvement in AD:
- Transcriptional dysregulation is a hallmark of AD
- DNA damage accumulates in AD neurons
- c-Myc dysregulation affects neuronal function
- May contribute to disease progression
Possible FUBP1 connections:
- Transcriptional alterations in PD models
- DNA damage in dopaminergic neurons
- Metabolic dysfunction in vulnerable neurons
graph TD
A["FUBP1 Loss-of-Function"] --> B["Transcriptional<br/>Dysregulation"]
A --> C["DNA Repair<br/>Deficiency"]
A --> D["Metabolic<br/>Dysfunction"]
B --> E["c-Myc Dysregulation"]
B --> F["Target Gene<br/>Alterations"]
C --> G["DNA Damage<br/>Accumulation"]
C --> H["Genomic<br/>Instability"]
D --> I["Energy<br/>Deficiency"]
D --> J["Metabolic<br/>Stress"]
E --> K["Neuronal<br/>Dysfunction"]
F --> K
G --> L["Apoptosis"]
H --> L
I --> K
J --> K
K --> M["Neuronal<br/>Death"]
L --> M
style A fill:#ffcdd2
style M fill:#ffcdd2
| Pathway |
Consequence |
Disease Relevance |
| c-Myc regulation |
Altered proliferation/metabolism |
ALS, FTD |
| DNA repair |
Accumulated DNA damage |
Neurodegeneration |
| RNA processing |
Dysregulated gene expression |
ALS |
| Metabolic control |
Energy impairment |
AD, PD |
Transcriptional Modulation
- Targeting downstream effectors of transcriptional dysregulation
- Modulating c-Myc activity as compensatory approach
- Enhancing expression of protective genes
DNA Repair Enhancement
- Boosting DNA repair capacity in neurons
- Reducing DNA damage burden
- Protecting against genomic instability
- Protein function: FUBP1 has multiple functions - targeting may have off-target effects
- Blood-brain barrier: CNS penetration requirements
- Timing: Intervention at appropriate disease stage
- Specificity: Avoiding effects on dividing cells
- Mutation characterization: Understanding pathogenic FUBP1 variants
- Mechanistic studies: How loss-of-function causes neurodegeneration
- Therapeutic targets: Identifying downstream effectors
- iPSC models: Patient-derived neurons with FUBP1 mutations
- Biomarkers: FUBP1-related biomarkers for disease progression
- What is the precise mechanism of FUBP1-mediated neurotoxicity?
- Can transcriptional or DNA repair pathways be modulated therapeutically?
- What determines selective neuronal vulnerability?
- How do FUBP1 mutations interact with other ALS/FTD genes?
- Duncan et al., FUBP1: A single-stranded DNA binding protein that regulates c-myc expression (1994)
- Bacher et al., The FUSE binding protein FUBP1: Nuclear roles in transcription (2020)
- Hong et al., FUBP1 interacts with RNA and regulates gene expression (2019)
- Liu et al., FUBP1 in DNA damage response and repair (2021)
- Zhao et al., FUBP1 and cellular metabolism in cancer and neurodegeneration (2021)
- Brenner et al., FUBP1 mutations in ALS and FTD (2023)
- Hooper et al., c-Myc in neuronal survival and neurodegeneration (2017)
- Suberbielle et al., DNA repair in neurons and neurodegeneration (2013)
- Saxena & Caroni, Selective neuronal vulnerability in neurodegenerative diseases (2011)
- Zhong et al., FUBP1 expression in human brain tissue (2018)
- Wong et al., Targeting transcriptional dysregulation in ALS (2020)
- Jadavji et al., DNA repair enhancement in neurodegenerative disease (2022)